Literature DB >> 27986424

Retinal Pigment Epithelium Degeneration Associated With Subretinal Drusenoid Deposits in Age-Related Macular Degeneration.

Xiaoyu Xu1, Xing Liu1, Xiaolin Wang2, Mark E Clark2, Gerald McGwin3, Cynthia Owsley2, Christine A Curcio2, Yuhua Zhang4.   

Abstract

PURPOSE: To test whether increased light transmission (hypertransmission) through subretinal drusenoid deposits (SDD) into the choroid in age-related macular degeneration (AMD) represented retinal pigment epithelium (RPE) degeneration.
DESIGN: Cross-sectional study.
METHODS: Nineteen eyes of 12 patients with early- to intermediate-stage AMD and 18 eyes of 12 normal subjects were evaluated with color fundus photography, optical coherence tomography (OCT), and high-resolution adaptive optics scanning laser ophthalmoscopy (AOSLO) at baseline and 24 months later. SDD were classified using an OCT-based 3-stage grading system. Hypertransmission beneath SDD into the choroid was examined in OCT. SDD microstructure was assessed with AOSLO. To characterize the hypertransmission-associated chorioretinal degeneration, choroidal thickness and photoreceptor length were measured in OCT at 1 mm and 2 mm superior, inferior, temporal, and nasal to the foveal center.
RESULTS: OCT disclosed hypertransmission beneath stage 3 SDD in 8 eyes. These lesions showed a distinctive regressing structure in AOSLO, compared with stage 3 lesions without hypertransmission. The phenomenon persisted at follow-up, and new hypertransmission developed as SDD advanced. In eyes with hypertransmission, choroids were thinner than those of normal eyes at all sites (by 44%-56%, P ≤ .0028) and those of eyes with SDD but without hypertransmission at superior and temporal sites (by 31%-46%, P ≤ .039). Photoreceptors were significantly shorter than those in normal eyes (by 6%-26%, P ≤ .0379).
CONCLUSIONS: Hypertransmission into the choroid, accompanied with SDD regression and thinning of choroid and photoreceptor layers, indicates RPE degeneration associated with advanced stages in the SDD life cycle.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27986424      PMCID: PMC5337135          DOI: 10.1016/j.ajo.2016.11.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  52 in total

1.  Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography.

Authors:  Giuseppe Querques; Florence Canouï-Poitrine; Florence Coscas; Nathalie Massamba; Lea Querques; Gerard Mimoun; Francesco Bandello; Eric H Souied
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

2.  Clinical features of reticular pseudodrusen according to the fundus distribution.

Authors:  Mee Yon Lee; Jaemoon Yoon; Don-Il Ham
Journal:  Br J Ophthalmol       Date:  2012-07-06       Impact factor: 4.638

3.  Microstructure of subretinal drusenoid deposits revealed by adaptive optics imaging.

Authors:  Alexander Meadway; Xiaolin Wang; Christine A Curcio; Yuhua Zhang
Journal:  Biomed Opt Express       Date:  2014-02-12       Impact factor: 3.732

4.  A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.

Authors:  Ramzi G Sayegh; Christian Simader; Ulrike Scheschy; Alessio Montuoro; Christopher Kiss; Stefan Sacu; David P Kreil; Christian Prünte; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2011-04-15       Impact factor: 12.079

5.  Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps.

Authors:  Paulina Haas; Marieh Esmaeelpour; Siamak Ansari-Shahrezaei; Wolfgang Drexler; Susanne Binder
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-25       Impact factor: 4.799

6.  Adaptive optics imaging of geographic atrophy.

Authors:  Kiyoko Gocho; Valérie Sarda; Sabrina Falah; José-Alain Sahel; Florian Sennlaub; Mustapha Benchaboune; Martine Ullern; Michel Paques
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

7.  Subretinal drusenoid deposits associated with pigment epithelium detachment in age-related macular degeneration.

Authors:  Florian Alten; Christoph R Clemens; Carolin Milojcic; Nicole Eter
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

8.  Multimodal imaging of autosomal dominant drusen.

Authors:  S A Zweifel; I Maygar; W Berger; P Tschuor; M Becker; S Michels
Journal:  Klin Monbl Augenheilkd       Date:  2012-04-11       Impact factor: 0.700

9.  Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus.

Authors:  C D Birnbach; M Järveläinen; D E Possin; A H Milam
Journal:  Ophthalmology       Date:  1994-07       Impact factor: 12.079

10.  Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft Drusen in vivo using adaptive optics imaging.

Authors:  Sarah Mrejen; Taku Sato; Christine A Curcio; Richard F Spaide
Journal:  Ophthalmology       Date:  2013-10-30       Impact factor: 12.079

View more
  19 in total

1.  DYNAMISM OF DOT SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION DEMONSTRATED WITH ADAPTIVE OPTICS IMAGING.

Authors:  Yuhua Zhang; Xiaolin Wang; Pooja Godara; Tianjiao Zhang; Mark E Clark; C Douglas Witherspoon; Richard F Spaide; Cynthia Owsley; Christine A Curcio
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

2.  Choroidal and Sub-Retinal Pigment Epithelium Caverns: Multimodal Imaging and Correspondence with Friedman Lipid Globules.

Authors:  Rosa Dolz-Marco; Jay P Glover; Orly Gal-Or; Katie M Litts; Jeffrey D Messinger; Yuhua Zhang; Mariano Cozzi; Marco Pellegrini; K Bailey Freund; Giovanni Staurenghi; Christine A Curcio
Journal:  Ophthalmology       Date:  2018-04-04       Impact factor: 12.079

3.  Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Ilaria Passerini; Simona Palchetti; Andrea Sodi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-27       Impact factor: 3.117

4.  Lifecycles of Individual Subretinal Drusenoid Deposits and Evolution of Outer Retinal Atrophy in Age-Related Macular Degeneration.

Authors:  Yuhua Zhang; Xiaolin Wang; Srinivas R Sadda; Mark E Clark; C Douglas Witherspoon; Richard F Spaide; Cynthia Owsley; Christine A Curcio
Journal:  Ophthalmol Retina       Date:  2019-10-31

5.  Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits.

Authors:  Dongwan Kang; Eun Gyu Yoon; Ki Tae Nam; Cheolmin Yun
Journal:  BMC Ophthalmol       Date:  2022-07-14       Impact factor: 2.086

6.  Adaptive optics for high-resolution imaging.

Authors:  Karen M Hampson; Raphaël Turcotte; Donald T Miller; Kazuhiro Kurokawa; Jared R Males; Na Ji; Martin J Booth
Journal:  Nat Rev Methods Primers       Date:  2021-10-14

7.  Hyperreflective Foci and Specks Are Associated with Delayed Rod-Mediated Dark Adaptation in Nonneovascular Age-Related Macular Degeneration.

Authors:  Benjamin S Echols; Mark E Clark; Thomas A Swain; Ling Chen; Deepayan Kar; Yuhua Zhang; Kenneth R Sloan; Gerald McGwin; Ramya Singireddy; Christian Mays; David Kilpatrick; Jason N Crosson; Cynthia Owsley; Christine A Curcio
Journal:  Ophthalmol Retina       Date:  2020-05-07

Review 8.  Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).

Authors:  Niamh Wynne; Joseph Carroll; Jacque L Duncan
Journal:  Prog Retin Eye Res       Date:  2020-11-06       Impact factor: 19.704

Review 9.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20

10.  Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration.

Authors:  Anna V Zarubina; Orly Gal-Or; Carrie E Huisingh; Cynthia Owsley; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.